Tarceva Trial Proves Positive, Pushes OSI, Genentech Stocks April 27, 2004 By Aaron Lorenzo No Comments Investors adored results from a Phase III trial of an experimental cancer drug, significantly driving up stock prices of two of the companies involved in its development. (BioWorld Today)Read More
MedImmune Reports Earnings, Signs Vaccine Deal With Cerus April 22, 2004 By Aaron Lorenzo No Comments
MedImmune Reports Earnings, Signs Vaccine Deal With Cerus April 22, 2004 By Aaron Lorenzo No Comments
ZymoGenetics Begins Phase II Study Of Its Thrombin Product April 20, 2004 By Aaron Lorenzo No Comments
Incara Brings In $10.3M Privately To Fund Studies Of AEOL 10150 April 20, 2004 By Aaron Lorenzo No Comments
ZymoGenetics Begins Phase II Study Of Its Thrombin Product April 20, 2004 By Aaron Lorenzo No Comments
Incara Brings In $10.3M Privately To Fund Studies Of AEOL 10150 April 20, 2004 By Aaron Lorenzo No Comments
